Study identifier:NIS-CDK-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
CARE - quality development in cardiovascular disease in general practice
cardiovascular disease
-
No
-
All
2193
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice
Location
Location
Arhus C, Denmark
Location
Brabrand, Denmark
Location
Erslev, Denmark
Location
Faaborg, Denmark
Location
Give, Denmark
Location
Greve, Denmark
Location
Hadsund, Denmark
Location
Hedehusene, Denmark
Arms | Assigned Interventions |
---|---|
1 Patients in secondary prevention of cardiovascular disease in primary care | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.